PRMT5 and hepatocellular carcinoma: Using Co-immunoprecipitation (co-IP) and mass spectrometry, protein arginine methyltransferase 5 (PRMT5) was identified as an interacting partner of AEG-1, and PRMT5 inhibition abrogated AEG-1-induced increases in the proliferation and migration of HCC cells [201].